IMEGLIMIN with Novel Process
IMEGLIMIN (Brand Name TWYMEEG) IS AN ORAL ANTI-DIABETIC MEDICATION.
A NEAR TERM LAUNCH OPPORTUNITY FOR GENERIC PHARMA MANUFACTURERS.
We help clients from world over develop, manufacture and innovate their small molecule medicines through our flow and batch synthesis.
